| 1 |
Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature |
|
|
| Uma Maheswari Krishnaswamy,Vinayak V. Maka,Murali Subramanian,Rohith Chitrapur,Nalini Kilara |
|
| Lymphoma. 2014; 2014: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Systematic review: Managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs |
|
|
| Selvarajah, V. and Montano-Loza, A.J. and Czaja, A.J. |
|
| Alimentary Pharmacology and Therapeutics. 2012; 36(8): 691-707 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Nonstandard drugs and feasible new interventions for autoimmune hepatitis: Part II |
|
|
| Czaja, A.J. |
|
| Inflammation and Allergy - Drug Targets. 2012; 11(5): 351-363 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Rituximab-induced pulmonary disease |
|
|
| OæConnor, M.B. and Abdullah, M.F.B. and OæDonovan, N. and Phelan, M.J. |
|
| Rheumatology International. 2012; 32(9): 2955-2956 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs |
|
|
| V. Selvarajah,A. J. Montano-Loza,A. J. Czaja |
|
| Alimentary Pharmacology & Therapeutics. 2012; 36(8): 691 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Rituximab-induced pulmonary disease |
|
|
| Mortimer B. O’Connor,Mohamad Fadri Bin Abdullah,Neil O’Donovan,Mark J. Phelan |
|
| Rheumatology International. 2012; 32(9): 2955 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
